Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kabir

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
The Lancet. Psychiatry|April 8, 2022
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analysesDaniel Freeman, Sinéad Lambe, Thomas Kabir, et al.
Trials|June 9, 2019
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)Belinda Lennox, Ksenija Yeeles, Peter B Jones, et al.
Psychological Medicine|April 3, 2023
The Oxford Agoraphobic Avoidance ScaleSinead Lambe, Jessica C Bird, Bao Sheng Loe, et al.
Psychological Medicine|April 28, 2022
Virtual reality (VR) therapy for patients with psychosis: satisfaction and side effectsDaniel Freeman, Laina Rosebrock, Felicity Waite, et al.
BMJ Open|August 30, 2019
Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange)Daniel Freeman, Ly-Mee Yu, Thomas Kabir, et al.
The Lancet. Psychiatry|April 3, 2025
INTEGRATE: international guidelines for the algorithmic treatment of schizophreniaRobert A McCutcheon, Toby Pillinger, Ioana Varvari, et al.
BMJ Open|June 22, 2022
Treating common mental disorder including psychotic experiences in the primary care improving access to psychological therapies programme (the TYPPEX study): protocol for a stepped wedge cluster randomised controlled trial with nested economic and process evaluation of a training package for therapistsPolly-Anna Ashford, Clare Knight, Margaret Heslin, et al.
The Lancet. Psychiatry|April 19, 2020
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health scienceEmily A Holmes, Rory C O'Connor, V Hugh Perry, et al.
BMJ Open|March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocolLumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
The Lancet. Psychiatry|April 8, 2022
Automated virtual reality therapy to treat agoraphobic avoidance and distress in patients with psychosis (gameChange): a multicentre, parallel-group, single-blind, randomised, controlled trial in England with mediation and moderation analysesDaniel Freeman, Sinéad Lambe, Thomas Kabir, et al.
Trials|June 9, 2019
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)Belinda Lennox, Ksenija Yeeles, Peter B Jones, et al.
Psychological Medicine|April 3, 2023
The Oxford Agoraphobic Avoidance ScaleSinead Lambe, Jessica C Bird, Bao Sheng Loe, et al.
Psychological Medicine|April 28, 2022
Virtual reality (VR) therapy for patients with psychosis: satisfaction and side effectsDaniel Freeman, Laina Rosebrock, Felicity Waite, et al.
BMJ Open|August 30, 2019
Automated virtual reality (VR) cognitive therapy for patients with psychosis: study protocol for a single-blind parallel group randomised controlled trial (gameChange)Daniel Freeman, Ly-Mee Yu, Thomas Kabir, et al.
The Lancet. Psychiatry|April 3, 2025
INTEGRATE: international guidelines for the algorithmic treatment of schizophreniaRobert A McCutcheon, Toby Pillinger, Ioana Varvari, et al.
BMJ Open|June 22, 2022
Treating common mental disorder including psychotic experiences in the primary care improving access to psychological therapies programme (the TYPPEX study): protocol for a stepped wedge cluster randomised controlled trial with nested economic and process evaluation of a training package for therapistsPolly-Anna Ashford, Clare Knight, Margaret Heslin, et al.
The Lancet. Psychiatry|April 19, 2020
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health scienceEmily A Holmes, Rory C O'Connor, V Hugh Perry, et al.
BMJ Open|March 19, 2026
Open-label randomised controlled trial of aripiprazole/sertraline combination in comparison with quetiapine for the clinical and cost-effectiveness of treatment of bipolar depression (the ASCEnD study): study protocolLumbini Azim, Sarah Al-Ashmori, Chrissie Butcher, et al.
Pageof 5